 CAESAREA, Israel, Feb. 10, 2021 GLOBE NEWSWIRE -- Itamar Medical Ltd. Itamar Medical or the Company Nasdaq: ITMR TASE: ITMR, a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the closing of its public offering of 3,506,499 American Depositary Shares ADSs, which includes the full exercise of the underwriters option to purchase additional 457,369 ADSs at a public offering price of 22.75 per ADS. The Company sold 2,196,499 ADSs and one of its shareholders, Viola Growth 2 A.V. Limited Partnership the Selling Shareholder, sold 1,310,000 ADSs in the offering. Each ADS represents 30 ordinary shares of the Company. The gross proceeds to the Company from the offering is approximately 50.0 million and the gross proceeds to the Selling Shareholder from the offering is approximately 29.8 million, before deducting the underwriting discounts and commissions and other offering expenses payable by the Company. 